in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.
.
at the funeral, a video of several photos of the valenzuela clan was shown.
.español
.
.